科興製藥(688136.SH)擬與創益科技簽訂房屋租賃及物業服務合同
格隆匯1月21日丨科興製藥(688136.SH)公佈,公司根據建立研發實驗室及實際業務發展需要,擬與公司關聯方創益生物科技有限公司(以下簡稱“創益科技”)簽署房屋租賃合同,承租創益科技大廈用於研發辦公,合同期三年,合同期租金總額(含租金、空調維護費、維修基金)不超過4142.70萬元。
科興製藥擬就上述租賃房產與公司關聯方正中產業控股集團有限公司及其子公司(以下簡稱“正中產控”)簽訂物業服務合同,合同期三年,合同期服務費用總額不超過565.10萬元。
創益科技大廈投入使用前,科興製藥將租賃正中產控所屬的科興科學園內C3棟4層臨時辦公,租賃費用(含租金、空調維護費、維修基金、物業費)預計不超過158.88萬元。
科興製藥擬向出租方正中產控出售現有辦公場所固定裝修,轉讓價格為347.05萬元。
綜上:科興製藥擬向創益科技及正中產控支付的租賃費用及物業費用共計4866.68萬元,擬向正中產控收取的現有辦公室裝修工程轉讓款項共計347.05萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.